Victoria Socha

DocwireNews

Worldwide, a significant number of kidneys are discarded due, in large part, to results from the preimplantation biopsy. Olivier Aubert, MD, PhD, and colleagues at the Paris Translational Research Center for Organ Transplantation, Paris, France, conducted a study to examine the value of preimplantation biopsies to predict long-term allograft outcome. Results were reported during an oral presentation session at Kidney Week 2019 in a presentation titled Absence of Additional Predictive Ability Value of Preimplantation Biopsies for Long-Term Allograft Outcome.The development cohort included patients who underwent kidney transplantation from a deceased donor in two French referral centers between 2004 and 2014; the donor organs had preimplantation biopsy results. The study also included two validation cohorts: 1107 deceased donors from Belgium and 1103 discarded kidneys based on biopsy results from the United States.There were 1629 patients in the development cohort. Preimplantation biopsy findings included interstitial fibrosis and tubular atrophy (IFTA), Banff cv and ah scores, and glomerulosclerosis percentage. Following adjustment for donor, recipient, and transplant characteristics, as well as for preimplantation biopsy findings and baseline immunological parameters, Kidney Donor Risk Index score (hazard ratio [HR], 2.50; 95% confidence interval [CI], 1.38-3.40; P&lt;.001), the presence of circulating donor-specific antibodies on the day of transplantation (HR, 1.76; 95% CI, 1.36-2.28; P&lt;.001), prior kidney transplantation (HR, 1.34; 95% CI, 1.01-1.78; P=.045), and the IFTA score (HR, 1.51; 95% CI, 1.00-2.26; P=.048) were identified as the main independent determinants of long-term allograft loss.However, there was no additional value in the biopsy results for the prediction of long-term allograft outcome compared with the model with no biopsy results. In the Belgium validation cohort, there were no associations with allograft loss with any of the biopsy results. Kidneys discarded based in histology results in the United States were matched with transplanted kidney in France. The French kidneys with histologic results similar to those of discarded US kidneys did not have worse allograft survival compared with the unmatched transplanted kidneys (P=.156).In conclusion, the authors said, &ldquo;Given this result and the fact that preimplantation biopsies increase the cold ischemia time, the current practice of discarding kidneys based on preimplantation biopsy results may not be optimal for allocation decision-making.&rdquo;Source: Aubert O, Raynaud M, Divard G, et al. Absence of additional predictive ability value of preimplantation biopsies for long-term allograft outcome. Abstract of an oral presentation at the American Society of Nephrology Kidney Week 2019 (Abstract TH-OR129), November 7, 2019, Washington, DC.

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Jordana Jampel

Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection

Infectious Disease

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Latest News

Efficacy of Allocation Decision-Making Based on Preimplantation Biopsy Results

Kidney Transplantation

Worldwide, a significant number of kidneys are discarded due, in large part, to results from the preimplantation biopsy. Olivier Aubert, MD, PhD, and colleagues at the Paris ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe